{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:09:01Z","timestamp":1781716141208,"version":"3.54.5"},"reference-count":15,"publisher":"Norwegian Medical Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.17.0171","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T06:48:29Z","timestamp":1516862909000},"source":"Crossref","is-referenced-by-count":1,"title":["Smertebehandling hos kreftpasienter i legemiddelassistert rehabilitering"],"prefix":"10.4045","volume":"138","author":[{"given":"Olav Magnus S.","family":"Fredheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"ref=1","unstructured":"Waal H, Bussesund K, Clausen T et al. Statusrapport 2015. Mot grensene for vekst og nytte. SERAF rapport 1\/2016. Oslo: SERAF, 2016."},{"key":"ref=2","unstructured":"Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet. Oslo: Helsedirektoratet, 2010."},{"key":"ref=3","unstructured":"Taveros\u00a0MC, Chuang\u00a0EJ. Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature. BMJ Support Palliat Care 2016; bmjspcare-2016-001126. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27566722&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fbmjspcare-2016-001126"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Eap\u00a0CB, Buclin\u00a0T, Baumann\u00a0P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002; 41: 1153\u201393. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12405865&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165%2F00003088-200241140-00003","DOI":"10.2165\/00003088-200241140-00003"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Fredheim\u00a0OM, Moksnes\u00a0K, Borchgrevink\u00a0PC et al. Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand 2008; 52: 879\u201389. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18331375&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fj.1399-6576.2008.01597.x","DOI":"10.1111\/j.1399-6576.2008.01597.x"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Moksnes\u00a0K, Dale\u00a0O, Rosland\u00a0JH et al. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. Eur J Cancer 2011; 47: 2463\u201370. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21775131&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ejca.2011.06.047","DOI":"10.1016\/j.ejca.2011.06.047"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Ferrari\u00a0A, Coccia\u00a0CP, Bertolini\u00a0A et al. Methadone\u2013metabolism, pharmacokinetics and interactions. Pharmacol Res 2004; 50: 551\u20139. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15501692&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.phrs.2004.05.002","DOI":"10.1016\/j.phrs.2004.05.002"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Greenwald\u00a0MK, Comer\u00a0SD, Fiellin\u00a0DA. Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy. Drug Alcohol Depend 2014; 144: 1\u201311. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25179217&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.drugalcdep.2014.07.035","DOI":"10.1016\/j.drugalcdep.2014.07.035"},{"key":"ref=9","unstructured":"Schmidt-Hansen\u00a0M, Bromham\u00a0N, Taubert\u00a0M et al. Buprenorphine for treating cancer pain. Cochrane Database Syst Rev 2015;  3: CD009596. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25826743&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2F14651858.CD009596.pub4"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Fredheim\u00a0OM, N\u00f8stdahl\u00a0T, Nordstrand\u00a0B et al. Behandling av akutte smerter under legemiddelassistert rehabilitering. Tidsskr Nor Laegeforen 2010; 130: 738\u201340. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20379336&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.09.1110","DOI":"10.4045\/tidsskr.09.1110"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Meyer\u00a0M, Wagner\u00a0K, Benvenuto\u00a0A et al. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol 2007; 110: 261\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17666599&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2F01.AOG.0000275288.47258.e0","DOI":"10.1097\/01.AOG.0000275288.47258.e0"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"van den Beuken-van Everdingen\u00a0MH, Hochstenbach\u00a0LM, Joosten\u00a0EA et al. Update on prevalence of pain in patiens with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016; 51: 1070\u20131090.e9. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27112310&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jpainsymman.2015.12.340","DOI":"10.1016\/j.jpainsymman.2015.12.340"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Fredheim\u00a0OM, Borchgrevink\u00a0PC, Nordstrand\u00a0B et al. Prescription of analgesics to patients in opioid maintenance therapy: a pharmacoepidemiological study. Drug Alcohol Depend 2011; 116: 158\u201362. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21277710&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.drugalcdep.2010.12.014","DOI":"10.1016\/j.drugalcdep.2010.12.014"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Fisher\u00a0K, Stiles\u00a0C, Hagen\u00a0NA. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage 2004; 28: 619\u201325. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15589088&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.jpainsymman.2004.03.003","DOI":"10.1016\/j.jpainsymman.2004.03.003"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Heiskanen\u00a0T, M\u00e4tzke\u00a0S, Haakana\u00a0S et al. Transdermal fentanyl in cachectic cancer patients. Pain 2009; 144: 218\u201322. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19442446&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.pain.2009.04.012","DOI":"10.1016\/j.pain.2009.04.012"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:45:23Z","timestamp":1781714723000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2018\/01\/klinisk-oversikt\/smertebehandling-hos-kreftpasienter-i-legemiddelassistert-rehabilitering"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,23]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.17.0171","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]}}}